{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-083888","form_type":"8-K","ticker":"ALTO","cik":"0000778164","company_name":"Alto Ingredients, Inc.","filed_at":"2023-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.988050+00:00","generated_at":"2026-06-08T21:39:35.494602+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Alto Ingredients Q3 net loss narrows to $3.8M; Adjusted EBITDA turns positive $4.7M","bullets":["Net sales $318.1M vs $336.9M YoY; gross profit improved to $4.2M from a loss of $19.8M.","Net loss $0.05 per share vs $0.39 YoY; includes $2.8M USDA grant.","Adjusted EBITDA of $4.7M vs negative $20.6M YoY; operating cash flow positive.","Extends EBITDA expansion goals by 6-12 months due to higher yeast project costs and inflation.","Cash $26.2M at Sep 30, 2023; total borrowing availability of $93.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-083888","json":"https://secwatch.observer/filing/0001213900-23-083888.json","markdown":"https://secwatch.observer/filing/0001213900-23-083888.md","text":"https://secwatch.observer/filing/0001213900-23-083888.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/778164/000121390023083888/0001213900-23-083888-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/778164/000121390023083888/ea187755-8k_altoing.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T21:39:35.494602+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39e4fdda43975b91090dfd40ca9db5b56fd537a4","claim":"Alto Ingredients, Inc. reported the nine months ended September 30, 2023 results: revenue $949.3 million, net income Net loss available to common stockholders ... was $10.0 million, or $0.14 per share, EPS $0.14 per share.","evidence_excerpt":"with an option to request up to an additional $25 million under the facility. Financial Results for the Nine Months Ended September 30, 2023 Compared to 2022 ● Net sales were $949.3 million, compared to $1,007.2 million. ● Cost of goods sold was $931.1 million, compared to $1,013.4 million. ● Gross profit was $18.2 million, compared to a gross loss of $6.2 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/778164/000121390023083888/0001213900-23-083888-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the nine months ended September 30, 2023"},{"label":"Revenue","value":"$949.3 million"},{"label":"Net income","value":"Net loss available to common stockholders ... was $10.0 million, or $0.14 per share"},{"label":"EPS","value":"$0.14 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"68c58600a4133a0b8271a7602d6c61173b45218b","claim":"Alto Ingredients, Inc. reported the quarter ended September 30, 2023 results: revenue $318.1 million, net income Net loss available to common stockholders ... was $3.8 million, or $0.05 per share, EPS $0.05 per share.","evidence_excerpt":"about the prospects and confident in our long-term growth strategy.” Financial Results for the Three Months Ended September 30, 2023 Compared to 2022 ● Net sales were $318.1 million, compared to $336.9 million. ● Cost of goods sold was $314.0 million, compared to $356.7 million. ● Gross profit was $4.2 million, compared to a gross loss of $19.8 million. ●","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/778164/000121390023083888/0001213900-23-083888-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$318.1 million"},{"label":"Net income","value":"Net loss available to common stockholders ... was $3.8 million, or $0.05 per share"},{"label":"EPS","value":"$0.05 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}